ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 23.42 billion. The enterprise value is 35.17 billion.

Market Cap	23.42B
Enterprise Value	35.17B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has increased by 0.74% in one year.

Current Share Class	n/a
Shares Outstanding	10.87M
Shares Change (YoY)	+0.74%
Shares Change (QoQ)	+2.76%
Owned by Insiders (%)	36.14%
Owned by Institutions (%)	n/a
Float	6.94M

Valuation Ratios

The trailing PE ratio is 36.53.

PE Ratio	36.53
Forward PE	n/a
PS Ratio	0.66
PB Ratio	0.58
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.14, with an EV/FCF ratio of -9.35.

EV / Earnings	54.48
EV / Sales	0.99
EV / EBITDA	11.14
EV / EBIT	25.52
EV / FCF	-9.35

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.36.

Current Ratio	1.84
Quick Ratio	0.77
Debt / Equity	0.36
Debt / EBITDA	4.69
Debt / FCF	-3.93
Interest Coverage	2.11

Financial Efficiency

Return on equity (ROE) is 1.57% and return on invested capital (ROIC) is 1.57%.

Return on Equity (ROE)	1.57%
Return on Assets (ROA)	1.28%
Return on Invested Capital (ROIC)	1.57%
Return on Capital Employed (ROCE)	3.01%
Revenue Per Employee	445.68M
Profits Per Employee	8.07M
Employee Count	80
Asset Turnover	0.53
Inventory Turnover	1.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.59% in the last 52 weeks. The beta is 0.92, so ENBIO's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-24.59%
50-Day Moving Average	2,211.20
200-Day Moving Average	2,348.28
Relative Strength Index (RSI)	45.41
Average Volume (20 Days)	9,154

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 35.65 billion and earned 645.61 million in profits. Earnings per share was 59.00.

Revenue	35.65B
Gross Profit	11.57B
Operating Income	1.38B
Pretax Income	884.64M
Net Income	645.61M
EBITDA	3.16B
EBIT	1.38B
Earnings Per Share (EPS)	59.00

Full Income Statement

Balance Sheet

The company has 3.05 billion in cash and 14.80 billion in debt, giving a net cash position of -11.75 billion or -1,081.54 per share.

Cash & Cash Equivalents	3.05B
Total Debt	14.80B
Net Cash	-11.75B
Net Cash Per Share	-1,081.54
Equity (Book Value)	41.37B
Book Value Per Share	3,704.75
Working Capital	18.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.90 billion and capital expenditures -8.66 billion, giving a free cash flow of -3.76 billion.

Operating Cash Flow	4.90B
Capital Expenditures	-8.66B
Free Cash Flow	-3.76B
FCF Per Share	-346.30

Full Cash Flow Statement

Margins

Gross margin is 32.46%, with operating and profit margins of 3.87% and 1.81%.

Gross Margin	32.46%
Operating Margin	3.87%
Pretax Margin	2.48%
Profit Margin	1.81%
EBITDA Margin	8.85%
EBIT Margin	3.87%
FCF Margin	n/a

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.74%
Shareholder Yield	-0.74%
Earnings Yield	2.76%
FCF Yield	-16.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.35
Piotroski F-Score	n/a